Cellular Biomedicine Group, Inc. (CBMG): Price and Financial Metrics


Cellular Biomedicine Group, Inc. (CBMG): $19.75

0.00 (0.00%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CBMG to Watchlist
Sign Up

Industry: China


Ranked

of 86

in industry

CBMG Stock Summary

  • With a price/sales ratio of 1,190.04, Cellular Biomedicine Group Inc has a higher such ratio than 99.15% of stocks in our set.
  • With a year-over-year growth in debt of 238.58%, Cellular Biomedicine Group Inc's debt growth rate surpasses 93.89% of about US stocks.
  • Revenue growth over the past 12 months for Cellular Biomedicine Group Inc comes in at 330.81%, a number that bests 97.85% of the US stocks we're tracking.
  • Stocks that are quantitatively similar to CBMG, based on their financial statements, market capitalization, and price volatility, are INO, MRSN, GERN, ATHX, and IMV.
  • Visit CBMG's SEC page to see the company's official filings. To visit the company's web site, go to www.cellbiomedgroup.com.

CBMG Stock Price Chart Interactive Chart >

Price chart for CBMG

CBMG Price/Volume Stats

Current price $19.75 52-week high $19.75
Prev. close $19.75 52-week low $11.48
Day low $19.73 Volume 171,900
Day high $19.75 Avg. volume 129,776
50-day MA $18.65 Dividend yield N/A
200-day MA $17.03 Market Cap 384.69M

Cellular Biomedicine Group, Inc. (CBMG) Company Bio


Cellular Biomedicine Group develops treatments for cancerous and degenerative diseases in China. The company was incorporated in 2001 and is based in Palo Alto, California.


CBMG Latest News Stream


Event/Time News Detail
Loading, please wait...

CBMG Latest Social Stream


Loading social stream, please wait...

View Full CBMG Social Stream

Latest CBMG News From Around the Web

Below are the latest news stories about Cellular Biomedicine Group Inc that investors may wish to consider to help them evaluate CBMG as an investment opportunity.

Cellular Biomedicine Group, Inc. Stockholders Approve Merger

Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) ("CBMG" or the "Company") announced that, at the Company's special meeting of stockholders held today, its stockholders approved the proposal to adopt the previously announced Agreement and Plan of Merger, dated as of August 11, 2020 (the "Merger Agreement"), by and among CBMG, CBMG Holdings ("Parent") and CBMG Merger Sub Inc., a wholly-owned subsidiary of Parent ("Merger Sub"). The Merger Agreement provides for the merger of Merger Sub with and into CBMG (the "Merger"), with CBMG surviving the Merger as a wholly-owned subsidiary of Parent. Upon the closing of the Merger, CBMG's stockholders will receive $19.75 per share in cash for each share of CBMG common stock they own.

Yahoo | February 8, 2021

Leading Proxy Advisory Firms Glass Lewis and ISS Recommend Cellular Biomedicine Group Stockholders Vote FOR Proposed Merger

ROCKVILLE, Md. and SHANGHAI , Jan. 28, 2021 /PRNewswire/ -- Cellular Biomedicine Group, Inc. (NASDAQ: CBMG ) ("Company," "CBMG," "we" or "our"), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, announced today that leading proxy advisory firms Glass, Lewis & Co. and Institutional Shareholder Services Inc. have both recommended that the Company's stockholders vote FOR the proposal to adopt the definitive merger agreement that provides for the acquisition of CBMG for $19.75 in cash per share of common stock in a going private transaction (the "merger proposal"). The Company will hold a special meeting of the stockholders on February 8, 2021 at 9:00 a.m. Eastern time , at 9605 Medical Center Drive, Sui...

Benzinga | January 28, 2021

SHAREHOLDER ALERT: Halper Sadeh LLP Investigates UROV, WTRE, CBMG, NAV; Shareholders Are Encouraged to Contact the Firm

NEW YORK, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Urovant Sciences Ltd. (NASDAQ: UROV) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Sumitovant Biopharma Ltd. for $16.25 per share. If you are an Urovant shareholder, click here to learn more about your rights and options. Watford Holdings Ltd. (NASDAQ: WTRE) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Arch Capital Group Ltd. for $35.00 per share. If you are a Watford shareholder, click here to learn more about your rights and options. Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) concern...

Yahoo | January 25, 2021

Lifshitz Law Firm, P.C. Announces Investigation of CBMG, HMSY, UROV, and WDR

NEW YORK, NY / ACCESSWIRE / January 18, 2021 / Lifshitz Law Firm, P.:Cellular Biomedicine Group, Inc.

Yahoo | January 18, 2021

ALERT: Halper Sadeh LLP Reminds Investors of Its Ongoing Merger Investigations; Shareholders are Encouraged to Contact the Firm – CBMG, CGIX, UROV

NEW YORK, Jan. 16, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to a consortium that includes members of Cellular Biomedicine management and several entities. If you are a Cellular Biomedicine shareholder, click here to learn more about your rights and options. Cancer Genetics, Inc. (NASDAQ: CGIX) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with StemoniX, Inc. Under the merger agreement, Cancer Genetics will acquire all of the outstanding capital stock of StemoniX...

Yahoo | January 16, 2021

Read More 'CBMG' Stories Here

CBMG Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year 6.18%
3-year -9.20%
5-year 34.54%
YTD 7.45%
2020 13.18%
2019 -8.04%
2018 56.98%
2017 -14.12%
2016 -39.04%

Continue Researching CBMG

Want to see what other sources are saying about Cellular Biomedicine Group Inc's financials and stock price? Try the links below:

Cellular Biomedicine Group Inc (CBMG) Stock Price | Nasdaq
Cellular Biomedicine Group Inc (CBMG) Stock Quote, History and News - Yahoo Finance
Cellular Biomedicine Group Inc (CBMG) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8677 seconds.